Trade Mark Journal No.2021/053 31 December 2021
WO0000001631366 (5)
Office of origin: United States of America
Date of International Registration:9 November 2021
Date of designation in the UK:
9 November 2021

International priority date claimed: 15 June 2021
(United States of America)
(90773805)
- Class 5
- Pharmaceuticals and pharmaceutical preparations for use in the treatment of genetic diseases and disorders.
Taysha Gene Therapies, Inc.
Representative: John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C., 530 Virginia Road, P.O. Box 9133, Concord MA 01742-9133, UNITED STATES OF AMERICA